Daily use is not standard and may increase risk
Its safety profile is similar to existing incretin-based therapies, making it a particularly promising candidate for obesity, type 2 diabetes, and related metabolic conditions
Like all medications, retatrutide and tirzepatide can cause side effects
The Bottom Line for Cash-Pay Patients Without Insurance The majority of people currently searching for GLP-1 programs online are cash-pay patients
The combined 8 mg group was tracking approximately 20-22% body weight reduction by week 30-36 in the phase 2 trial
Tirzepatide drugs like Zepbound continue to cause severe injuries, like vision loss, pancreatitis, blood clots, and a range of serious gastrointestinal injuries, in some patients